Is impaired Kupffer cell function really important to the pathogenesis of nonalcoholic steatohepatitis?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 4, 2012, Pages 622-624

  Ono, Masafumi ^a   Saibara, Toshiji ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD163 ANTIGEN; CD68 ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

CYTOKINE PRODUCTION; DISEASE SEVERITY; EDITORIAL; KUPFFER CELL; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84858833443     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2012.07084.x     Document Type: Editorial

References (21)

1. Creely SJ, McTernan PG, Kusminski CM etal. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 2007; 292: E740-7.
2. Loffreda S, Yang SQ, Lin HZ etal. Leptin regulates proinflammatory immune responses. FASEB J. 1998; 12: 57-65.
3. Diehl AM. Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines. Am. J. Physiol. Gastrointest. Liver Physiol. 2002; 282: G1-5.
4. Solga SF, Diehl AM. Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics. J. Hepatol. 2003; 38: 681-7.
5. Fox ES, Broitman SA, Thomas P. Bacterial endotoxins and the liver. Lab. Invest. 1990; 63: 733-41.
6. Laskin DL, Weinberger B, Laskin JD. Functional heterogeneity in liver and lung macrophages. J. Leukoc. Biol. 2001; 70: 163-70.
7. Park JW, Jeong G, Kim SJ, Kim MK, Park SM. Predictors reflecting the pathological severity of non-alcoholic fatty liver disease: comprehensive study of clinical and immunohistochemical findings in younger Asian patients. J. Gastroenterol. Hepatol. 2007; 22: 491-7.
8. Baffy G. Kupffer cells in non-alcoholic fatty liver disease: the emerging view. J. Hepatol. 2009; 51: 212-23.
9. Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc. Natl. Acad. Sci. U.S.A. 1997; 94: 2557-62.
10. Velayudham A, Dolganiuc A, Ellis M etal. VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice. Hepatology 2009; 49: 989-97.
11. Li Z, Yang S, Lin H etal. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 2003; 37: 343-50.
12. Su GL. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am. J. Physiol. 2002; 283: G256-65.
13. Ferrero E, Jiao D, Tsuberi BZ etal. Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. Proc. Natl. Acad. Sci. U.S.A. 1993; 90: 2380-4.
14. Haziot A, Ferrero E, Köntgen F etal. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 1996; 4: 407-14.
15. Ikejima K, Enomoto N, Seabra V, Ikejima A, Brenner DA, Thurman RG. Pronase destroys the lipopolysaccharide receptor CD14 on Kupffer cells. Am. J. Physiol. 1999; 276: G591-8.
16. Leicester KL, Olynyk JK, Brunt EM, Britton RS, Bacon BR. Differential findings for CD14-positive hepatic monocytes/macrophages in primary biliary cirrhosis, chronic hepatitis C and nonalcoholic steatohepatitis. Liver Int. 2006; 26: 559-65.
17. Ward J, Guthrie JA, Scott DJ etal. Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis. Radiology 2000; 216: 154-62.
18. Tomita K, Tanimoto A, Irie R etal. Evaluating the severity of nonalcoholic steatohepatitis with superparamagnetic iron oxide-enhanced magnetic resonance imaging. J. Magn. Reson. Imaging 2008; 28: 1444-50.
19. Asanuma T, Ono M, Kubota K etal. Super paramagnetic iron oxide MRI shows defective Kupffer cell uptake function in non-alcoholic fatty liver disease. Gut 2010; 59: 258-66.
20. Moriyasu F, Iijima H, Tsuchiya K etal. Diagnosis of NASH using delayed parenchymal imaging of contrast ultrasound. Hepatol. Res. 2005; 33: 97-9.
21. Tonan T, Fujimoto K, Qayyum A etal. CD14 expression and Kupffer cell dysfunction in non-alcoholic steatohepatitis: Superparamagnetic iron oxide-magnetic resonance image and pathologic correlation. J. Gastroenterol. Hepatol. 2012; 27: 789-96.